期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 172, 期 2, 页码 290-293出版社
WILEY-BLACKWELL
DOI: 10.1111/bjh.13480
关键词
refractory Hodgkin lymphoma; biomodulatory therapy; metronomic therapy; pioglitazone; everolimus